KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Asset Writedowns and Impairment (2022 - 2025)

Amgen has reported Asset Writedowns and Impairment over the past 4 years, most recently at $400.0 million for Q3 2025.

  • Quarterly results put Asset Writedowns and Impairment at $400.0 million for Q3 2025, up 555.74% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (up 654.72% YoY), and the annual figure for FY2025 was $1.2 billion, up 654.72%.
  • Asset Writedowns and Impairment for Q3 2025 was $400.0 million at Amgen, down from $800.0 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for AMGN hit a ceiling of $851.0 million in Q4 2023 and a floor of $2.0 million in Q4 2022.
  • Median Asset Writedowns and Impairment over the past 4 years was $64.5 million (2024), compared with a mean of $277.1 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: skyrocketed 42450.0% in 2023 and later plummeted 96.47% in 2024.
  • Amgen's Asset Writedowns and Impairment stood at $2.0 million in 2022, then skyrocketed by 42450.0% to $851.0 million in 2023, then plummeted by 96.47% to $30.0 million in 2024, then surged by 1233.33% to $400.0 million in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $400.0 million (Q3 2025), $800.0 million (Q1 2025), and $30.0 million (Q4 2024) per Business Quant data.